Details for New Drug Application (NDA): 017108
✉ Email this page to a colleague
NDA 017108 describes WESTADONE, which is a drug marketed by Sandoz and is included in one NDA. Additional details are available on the WESTADONE profile page.
The generic ingredient in WESTADONE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
The generic ingredient in WESTADONE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
Summary for 017108
| Tradename: | WESTADONE |
| Applicant: | Sandoz |
| Ingredient: | methadone hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017108
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DISPERSIBLE;ORAL | Strength | 2.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EFFERVESCENT;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EFFERVESCENT;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
